New Procedure for the Granting of Marketing Authorizations for Biological Products
The Chilean Public Health Institute (ISP) has issued Resolution Exenta No. E679/2025, establishing an internal procedure for the application of a reliance mechanism in the granting of marketing authorizations for biological pharmaceutical products. This mechanism will allow products approved by at least two high-surveillance regulatory agencies (such as the FDA, EMA, MHRA, among others) to …
New Procedure for the Granting of Marketing Authorizations for Biological Products Read More »